Company: ERAS
Filing Date: 2025-05-15
Form Type: SCHEDULE 13G/A
Source: 0001415889-25-012990
Chunk: 0

Company: Erasca, Inc.
Filing Date: 2025-05-15
Form: SCHEDULE 13G/A
Chunk 0
---
 11 is calculated based on 283,265,716 shares of Common Stock outstanding on March 13, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on March 20, 2025.

| SCHEDULE 13G |

| CUSIP No. | 29479A108 |

| 1                                                                  |                                                                            FHMLSP, L.P. |
| 2                                                                  |                                                                                   -a)(b |
| 3                                                                  |                                                                            Sec Use Only |
| 4                                                                  |                                                                                DELAWARE |
| Number of Shares Beneficially Owned by Each Reporting Person With: |                                                                      5           0.00   
                                                                      6  14,929,001.00   
                                                                      7           0.00   
                                                                        8  14,929,001.00 |
| 9                                                                  |                                                                           14,929,001.00 |
| 10                                                                 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) |
| 11                                                                 |                                                                                   5.3 % |
| 12                                                                 |                                                                                      PN |

Comment for Type of Reporting Person:The shares listed in rows 6, 8 and 9 consist of 14,929,001 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. The percentage listed in row 11 is calculated based on 283,265,716 shares of Common Stock outstanding on March 13, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on March 20, 2025.

| SCHEDULE 13G |

| CUSIP No. | 29479A108 |

| 1                                                                  |                                                                          FHMLSP, L.L.C. |
| 2                                                                  |                                                                                   -a)(b |
| 3                                                                  |                                                                            Sec Use Only |
| 4                                                                  |                                                                                DELAWARE |
| Number of Shares Beneficially Owned